Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Clinical utility of investigations in triple-negative thrombocytosis: A real-world, multicentre evaluation of UK practice.

Godfrey AL. et al, (2024), Br J Haematol

Quantitative analysis of bone marrow fibrosis highlights heterogeneity in myelofibrosis and augments histological assessment: An Insight from a phase II clinical study of zinpentraxin alfa

Ryou H. et al, (2024), HemaSphere, 8

Nasopharyngeal myeloid sarcoma as a manifestation of acute monomyelocytic leukaemia.

Pervaiz A. et al, (2023), BMJ case reports, 16

Quantitative interpretation of bone marrow biopsies in MPN-What's the point in a molecular age?

Ryou H. et al, (2023), Br J Haematol, 203, 523 - 535

Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients.

Ryou H. et al, (2023), Leukemia, 37, 348 - 358

Correction: Continuous Indexing of Fibrosis (CIF): improving the assessment and classification of MPN patients.

Ryou H. et al, (2023), Leukemia, 37

Loss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma.

Gooding S. et al, (2022), Blood, 140, 1816 - 1821

Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies.

Mughal TI. et al, (2022), Hematol Oncol, 40, 491 - 504

Multi-Scale Graphical Representation of Cell Environment.

Theissen H. et al, (2022), Annu Int Conf IEEE Eng Med Biol Soc, 2022, 3522 - 3525

In utero origin of myelofibrosis presenting in adult monozygotic twins.

Sousos N. et al, (2022), Nat Med, 28, 1207 - 1211

Artificial Intelligence-Based Quantitative and Topological Analysis of Plasma Cell Burden: A New Tool for the Assessment of Myeloma

Lomas OC. et al, (2022), BLOOD, 140, 12603 - 12604

Continuous Indexing of Fibrosis (CIF): Improving the Assessment and Classification of MPN Patients

Ryou H. et al, (2022)

Cross-Talk between Hematopoietic Cells and Fibroblast Subsets Drives Inflammation and Remodelling of the Bone Marrow Microenvironment in Myeloproliferative Neoplasms

Li R. et al, (2022), BLOOD, 140, 1091 - 1092

LARP1 regulates metabolism and mTORC1 activity in cancer

Chettle J. et al, (2022)

Learning Cellular Phenotypes through Supervision.

Theissen H. et al, (2021), Annu Int Conf IEEE Eng Med Biol Soc, 2021, 3592 - 3595

The management of Castleman disease.

Lomas OC. et al, (2021), Br J Haematol, 195, 328 - 337

A Phase 2a cohort expansion study to assess the safety, tolerability, and preliminary efficacy of CXD101 in patients with advanced solid-organ cancer expressing HR23B or lymphoma.

Booth SW. et al, (2021), BMC Cancer, 21

Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm Biology.

Royston D. et al, (2021), Hematol Oncol Clin North Am, 35, 279 - 293

Application of Single-Cell Approaches to Study Myeloproliferative Neoplasm

Royston D. et al, (2021), HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 35, 279 - 293

Artificial intelligence-based morphological fingerprinting of megakaryocytes: a new tool for assessing disease in MPN patients.

Sirinukunwattana K. et al, (2020), Blood Adv, 4, 3284 - 3294

Load More

Include forthcoming?